)
Clinica Baviera (CBAV) investor relations material
Clinica Baviera Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Revenue grew 10% year-over-year to €169.9 million in H1 2026, with all countries contributing to growth.
Net income increased 17% to €26.7 million compared to H1 2025.
EBITDA rose 14% to €50.6 million, with margin improvements in Spain and Italy.
Expansion continued with new clinics in Spain, Germany, and Italy, supporting sales growth.
Financial highlights
Operating expenses increased 8% year-over-year, reaching €119.4 million.
EBIT grew 12% to €37.1 million, while profit before taxes rose 14% to €37.1 million.
Cash flow from operations was stable at €42.9 million.
CAPEX totaled €12.4 million, mainly for new openings and renovations.
Outlook and guidance
New clinics in Spain, Germany, and Italy are expected to drive further growth.
The Rome clinic in Italy is set to begin operations in September, supporting continued expansion.
- Q1 2026 saw 8% revenue growth and 14% higher net income, driven by clinic expansion.CBAV
Q1 2026 - Revenue and net profit rose double digits, with strong expansion and improved financial position.CBAV
Q4 2025 - Revenue up 16% and EBITDA up 12% year-over-year, with strong expansion and share price growth.CBAV
Q3 2025 - Revenue up 18% to €154.7M; EBITDA and core market growth offset UK and Italy headwinds.CBAV
Q2 2025 - Revenue up 16% and UK expansion via Optimax acquisition mark a growth-focused quarter.CBAV
Q3 2024 - Double-digit growth and a strategic UK acquisition drove strong 1H 2024 results.CBAV
Q2 2024 - Revenue up 21% and net income up 4% in Q1 2025, with strong cash position.CBAV
Q1 2025 - Double-digit growth, UK expansion, and higher dividends drive strong 2024 results.CBAV
Q4 2024
Next Clinica Baviera earnings date
Next Clinica Baviera earnings date
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)